Skip to main content
You have permission to edit this article.
Edit
Editorial: New vaccine to ramp up Oklahoma rollout by month's end

Editorial: New vaccine to ramp up Oklahoma rollout by month's end

  • Updated
  • 0
{{featured_button_text}}

Getting a vaccine is expected to be easier by the month’s end, particularly with the approval of the single-shot COVID-19 vaccine from Johnson & Johnson.

Oklahoma has been doing well in getting residents inoculated, ranking No. 7 in the U.S. when adding the state, tribal and Veterans Affairs vaccine efforts. A bit more than 1 million doses have been administered, and the feedback we’ve gotten from people in the vaccination lines is that both state and local officials have organized them well, treated patients gently and got things handled quickly.

Still, residents are frustrated by the state’s health department portal, unable to secure an appointment or driving long distances to obtain one. A lack of vaccine supply has been the biggest obstacle.

That is likely to change as more vaccines are allotted to the state, including the latest given the green light by the U.S. Centers for Disease Control and Prevention. The Johnson & Johnson vaccine will join those already in U.S. distribution from Moderna and Pfizer.

In a recent meeting with the Tulsa World editorial board, Gov. Kevin Stitt said the vaccine supply and demand situation is likely to flip soon. Instead of there being more demand than supply, supply will outpace demand in the state by the end of March or early April, he predicted. That would be a welcome turn of events for sure.

The state plans to prioritize the single-shot doses for hard-to-track populations, such as people who are homeless. It’s a smart approach to ensure vulnerable populations are not left unprotected.

The two-dose versions have impressive efficacy of 94% to 95%. The Johnson & Johnson vaccine is 66% effective overall, but prevents severe disease 85% of the time and prevents COVID-19 deaths at 100%.

The new vaccine is safe and effective. The U.S. Food and Drug Administration granted it emergency use authorization after a massive test that spanned three continents.

Its approval will help speed the pandemic’s end quickly and safely.

The most respected U.S. infectious disease expert, Dr. Anthony Fauci, called the three available vaccines “highly efficacious” and encouraged Americans to take whichever one is available to them. He estimates 75% to 85% of Americans need to be immunized to reach herd immunity.

Oklahomans appear to be taking that advice with such enthusiasm that the state hasn’t been able to keep up with the need, a problem that should be easing in a month.


Featured video:

Tulsa World Editorial Pages Editor Wayne Greene reads the newspaper’s Jan. 7 editorial.

Subscribe to Daily Headlines

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Catch the latest in Opinion

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Best known to the public for his four years in Congress from eastern Oklahoma's 2nd District, Carson has legitimate academic credentials. He grew up in Jenks, earned his bachelor's degree at Baylor University with Phi Beta Kappa honors, attended Oxford University as a Rhodes Scholar and earned a law degree from the University of Oklahoma. He is currently on the faculty at the University of Virginia, teaching courses in national security and the public sector.

  • Updated

Shrum is a public college and Oklahoma higher education success story, the editorial says. A native of Coweta, she did undergraduate work at Connor State College, Northeastern State University and the University of Arkansas. She earned her medical degree at OSU College of Osteopathic Medicine. She also has completed executive leadership and management training programs at Harvard University and Stanford University.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News